Demo Data from SIGIR 2026 / reviewers in the wild / expert
Elizabeth Kelly
dblp:76/7238
· DBLP profile ↗
5ranked-venue papers
0as first author
4since 2021 · last 2025
—ORCID · conflict
Domains — the database's venue-derived domains; a paper can count in several
Human-computer interaction and ubiquitous computing · 3 · 3 since 2021Applied, interdisciplinary, general and emerging computing · 2 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Human-computer interaction and pervasive computing
1 paper |
Games and playful interaction · 38% Collaborative and social computing · 38% Interaction techniques and input · 12% |
Topics — the 4 heaviest of 4, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Collaborative and social computing
audience experience |
0.6 | 1 | 2022 | Crafting Trajectories of Smart Phone Use at the Opera · ACM Trans. Comput. Hum. Interact. 2022 |
Games and playful interaction › interactive art
audience participation |
0.6 | 1 | 2022 | Crafting Trajectories of Smart Phone Use at the Opera · ACM Trans. Comput. Hum. Interact. 2022 |
Ubiquitous computing and smart environments › mobile computing
mobile app usage |
0.2 | 1 | 2022 | Crafting Trajectories of Smart Phone Use at the Opera · ACM Trans. Comput. Hum. Interact. 2022 |
Interaction techniques and input › mobile interaction
mobile phone interaction |
0.2 | 1 | 2022 | Crafting Trajectories of Smart Phone Use at the Opera · ACM Trans. Comput. Hum. Interact. 2022 |
Methods — techniques the papers use, named apart from their topics
field study · 0.6design trajectories · 0.6
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | National COVID Cohort Collaborative data enhancements: a path for expanding common data modelsabstractOBJECTIVE: To support long COVID research in National COVID Cohort Collaborative (N3C), the N3C Phenotype and Data Acquisition team created data designs to aid contributing sites in enhancing their data. Enhancements include long COVID specialty clinic indicator; Admission, Discharge, and Transfer transactions; patient-level social determinants of health; and in-hospital use of oxygen supplementation. MATERIALS AND METHODS: For each enhancement, we defined the scope and wrote guidance on how to prepare and populate the data in a standardized way. RESULTS: As of June 2024, 29 sites have added at least one data enhancement to their N3C pipeline. DISCUSSION: The use of common data models is critical to the success of N3C; however, these data models cannot account for all needs. Project-driven data enhancement is required. This should be done in a standardized way in alignment with common data model specifications. Our approach offers a useful pathway for enhancing data to improve fit for purpose. CONCLUSION: In this initiative, we rapidly produced project-specific data modeling guidance and documentation in support of long COVID research while maintaining a commitment to terminology standards and harmonized data. Kellie M. Walters, Marshall Clark, Sofia Dard, Stephanie S. Hong, Elizabeth Kelly, Kristin Kostka, Adam M. Lee, Robert T. Miller, Michele Morris, Matvey Palchuk, Emily R. Pfaff, Adam B. Wilcox, Alexis Graves, Alfred Anzalone, Amin Manna, Amit Saha, Amy Olex, Andrea Zhou, Andrew E. Williams, Andrew Southerland, Andrew T. Girvin, Anita Walden, Anjali A Sharathkumar, Benjamin R. C. Amor, Benjamin Bates, Brian Hendricks, Caleb Alexander, Carolyn T. Bramante, Cavin Ward-Caviness, Charisse R. Madlock-Brown, Christine Suver, Christopher G. Chute, Christopher Dillon, Chunlei Wu, Clare Schmitt, Cliff Takemoto, Dan Housman, Davera Gabriel, David Eichmann, Diego Mazzotti, Don Brown, Eilis A. Boudreau, Elaine L. Hill, Elizabeth Zampino, Emily Carlson Marti, Evan French, Farrukh M. Koraishy, Federico Mariona, Fred W. Prior, George Sokos, Greg Martin, Harold P. Lehmann, Heidi Spratt, Hemalkumar Mehta, Hythem Sidky, J. W. Awori Hayanga, Jami Pincavitch, Jaylyn Clark, Jeremy Richard Harper, Jessica Islam, Jin Ge, Joel Gagnier, Joel H. Saltz, Johanna Loomba, John Buse, Jomol P. Mathew, Joni L. Rutter, Julie A. McMurry, Justin Guinney, Justin Starren, Karen Crowley, Katie Rebecca Bradwell, Ken Wilkins, Kenneth R. Gersing, Kenrick Dwain Cato, Kimberly Murray, Lavance Northington, Lee Allan Pyles, Leonie Misquitta, Lesley Cottrell, Lili M. Portilla, Mariam Deacy, Mark M. Bissell, Mary Emmett, Mary Morrison Saltz, Melissa A. Haendel, Meredith C. B. Adams, Meredith Temple-O'Connor, Michael G. Kurilla, Nabeel Qureshi, Nasia Safdar, Nicole Garbarini, Noha Sharafeldin, Ofer Sadan, Patricia A. Francis, Penny Wung Burgoon, Peter N. Robinson, Philip R. O. Payne, Rafael Fuentes, Randeep Jawa, Rebecca Erwin-Cohen, Rena Patel, Richard A. Moffitt, Richard L. Zhu, Rishi Kamaleswaran, Robert Hurley, Saiju Pyarajan, Samuel G. Michael, Samuel Bozzette, Sandeep Mallipattu, Satyanarayana Vedula, Scott Chapman, Shawn T. O'Neil, Soko Setoguchi, Tellen D. Bennett, Tiffany Callahan, Umit Topaloglu, Usman Sheikh, Valery Gordon, Vignesh Subbian, Warren A. Kibbe, Wenndy Hernandez, Will Beasley, Will Cooper, William Hillegass, Xiaohan Tanner Zhang |
J. Am. Medical Informatics Assoc. | 5 |
| 2022 | Crafting Trajectories of Smart Phone Use at the OperaabstractLosing Her Voice is a new opera which highlights the challenges of subtly interweaving digital technologies into established cultural forms. Audience members were encouraged to use their own mobile phones to interact with on-stage projections before, during and after the performance. We chart the trajectories of participation that were designed into the premiere performances of this work, and how these unfolded in practice. We identify the strategies that were effective to: encourage the adoption of the mobile app; interweave use with the other elements of the opera performance; make it consistent with the content; and ensure it complemented but was not essential to the show. We highlight the way in which three canonical trajectories must be woven together in this experience: the standard trajectory of “a night at the opera”; the dramatic arc of the specific work, and the audience member's use of their own device. Christopher Greenhalgh, Adrian Hazzard, Steve Benford, Laurence Cliffe, Elizabeth Kelly |
ACM Trans. Comput. Hum. Interact. | 5 |
| 2021 | From AI, creativity and music to IoT, HCI, musical instrument design and audio interaction: a journey in sound
Alan Chamberlain, Adrian Hazzard, Elizabeth Kelly, Mads Bødker, Maria Kallionpää |
Pers. Ubiquitous Comput. | 3 |
| 2021 | Correction to: from AI, creativity and music to IoT, HCI, musical instrument design and audio interaction: a journey in sound
Alan Chamberlain, Adrian Hazzard, Elizabeth Kelly, Mads Bødker, Maria Kallionpää |
Pers. Ubiquitous Comput. | 3 |
| 2015 | Reconciling Estimates of Cell Proliferation from Stable Isotope Labeling ExperimentsabstractStable isotope labeling is the state of the art technique for in vivo quantification of lymphocyte kinetics in humans. It has been central to a number of seminal studies, particularly in the context of HIV-1 and leukemia. However, there is a significant discrepancy between lymphocyte proliferation rates estimated in different studies. Notably, deuterated (2)H2-glucose (D2-glucose) labeling studies consistently yield higher estimates of proliferation than deuterated water (D2O) labeling studies. This hampers our understanding of immune function and undermines our confidence in this important technique. Whether these differences are caused by fundamental biochemical differences between the two compounds and/or by methodological differences in the studies is unknown. D2-glucose and D2O labeling experiments have never been performed by the same group under the same experimental conditions; consequently a direct comparison of these two techniques has not been possible. We sought to address this problem. We performed both in vitro and murine in vivo labeling experiments using identical protocols with both D2-glucose and D2O. This showed that intrinsic differences between the two compounds do not cause differences in the proliferation rate estimates, but that estimates made using D2-glucose in vivo were susceptible to difficulties in normalization due to highly variable blood glucose enrichment. Analysis of three published human studies made using D2-glucose and D2O confirmed this problem, particularly in the case of short term D2-glucose labeling. Correcting for these inaccuracies in normalization decreased proliferation rate estimates made using D2-glucose and slightly increased estimates made using D2O; thus bringing the estimates from the two methods significantly closer and highlighting the importance of reliable normalization when using this technique. Raya Ahmed, Liset Westera, Julia Drylewicz, Marjet Elemans, Elizabeth Kelly, Rajko Reljic, Kiki Tesselaar, Rob J. De Boer, Derek C. Macallan, José A. M. Borghans, Becca Asquith |
PLoS Comput. Biol. | 6 |